Skip to main content
Clifford Harding III, MD, Pathology, Cleveland, OH

Clifford Vincent Harding III MD

Pathology•Cleveland, OH

Anatomic Pathology, Clinical Pathology

Professor & Chair of Pathology, Case Western Reserve Univ./University Hospitals Case Medical Ct

Join to view full profile

  • Pathology, Wolstein 65222103 Cornell RdCleveland, OH 44106

  • Phone+1 216-368-3611

Dr. Harding is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Harding's full profileAlready have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1985 - 1990
  • WashU Medicine
    WashU MedicineClass of 1985
  • Harvard University
    Harvard UniversityA.B., Biology, Magna cum laude, 1975 - 1979

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1993 - 2018

Awards, Honors, & Recognition

  • Fellow American Association for the Advancement of Science, 2012
  • Scholar Pfizer, 1991
  • Junior Faculty Research Award American Cancer Society, 1991

Publications & Presentations

PubMed

Journal Articles

  • Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes  
    Mudd, J.C., Murphy, P., Manion, M., Debernardo, R., Hardacre, J., Ammori, J., Hardy, G.A., Harding, C.V., Mahabaleshwar, G.H., Jain, M.K., Jacobson, J.M., Brooks, A.D...., Blood, 1/1/2013
  • Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers  
    Hardy, G.A.D., Sieg, S., Rodriguez, B., Anthony, D., Asaad, R., Jiang, W., Mudd, J., Schacker, T., Funderburg, N., Pilch, H., Rabin, R.L., Lederman, M.M. and Harding, ..., PLOS One, 1/1/2013
  • Type I interferon drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing  
    Simmons, D.P., Wearsch, P.A., Canaday, D.H., Meyerson, H.J., Liu, Y.C., Wang, Y., Boom, W.H. and Harding, C.V., J. Immunol., 1/1/2012

Press Mentions

  • Citywide Collaboration Awarded $46 Million Grant to Improve Regional Health
    Citywide Collaboration Awarded $46 Million Grant to Improve Regional HealthJune 26th, 2018

Grant Support

  • Immunology Training Program - PredoctoralNational Institute Of Allergy And Infectious Diseases2010–2012
  • M. Tuberculosis Lipoprotein-Tlr2 InteractionsNational Institute Of Allergy And Infectious Diseases2007–2011
  • Medical Scientist Training ProgramNational Institute Of General Medical Sciences2001–2011
  • Bacterial And Liposomal Antigen ProcessingNational Institute Of Allergy And Infectious Diseases1994–2011
  • Class II MHC Transport And FunctionNational Institute Of Allergy And Infectious Diseases1994–2010

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Clifford Harding, Dr. Clifford Harding, MD, Dr. C Harding, Dr. Clifford Vincent Harding